ICNC2018 Abstracts & Symposia Proposals, ICNC 2014

Font Size: 
De novo gain-of-function mutation in SCN11A: No pain, More pain, or a bit of Both?
Mohamed Osman Eltahir Babiker, Iain Horrocks, John Tolmie, Catherine McWilliam, Paula Beattie, Juliet Tucker, Christopher Geoff Woods

Building: Bourbon Cataratas Convention Centre, Foz do Iguaçu
Room: Cataratas II
Date: 2014-05-08 04:45 PM – 05:00 PM
Last modified: 2014-02-09

Abstract


Background:

The genotypic and phenotypic spectrum of pain-related channelopathies is expanding. Various mutations in the genes encoding voltage-gated sodium channels have been identified. This is best exemplified in SCN9A gene mutations whereby loss-of-function mutations lead to indifference to pain.1,2 Conversely, gain-of-function mutations result in paroxysmal extreme pain disorder and primary erythermalgia.3 Recently, Leipold et al. (2013) reported 2 cases of congenital insensitivety to pain due to a de novo gain-of-function mutation in SCN11A.4 Clinically, patients had universal loss of pain perception and self-inflicted injuries.

 

Aim:

To describe a case with a similar SCN11A mutation in whom a mixed picture of pain insensitivity and episodic visceral pain predominates.

 

Case report:

This 6-year-old girl had a history of chronic diarrhoea and failure to thrive during the first year of life. Difficult-to-heal wounds were noted. Moreover, she had mouth ulcers that were self-inflicted by biting. Cognitive development was normal. Motor development was slightly delayed with generalized hypotonia and weakness. She then started to have abdominal pain made worse by defecation and urination.  Other symptoms were excessive sweating, persistent pruritus and cold intolerance. A de novo heterozygous mutation in SCN11A which encodes one of the sodium channels (Nav1.9) was found. This was a p.Leu811Pro missense gain-of-function mutation.

 

Discussion & Conclusion:

This case expands the phenotype of a novel mutation in a gene encoding a voltage-gated sodium channel. Mutational analysis of SCN11A gene in similar cases is recommended. Studies to increase understanding of pain pathways and targeted treatments are needed.

 


Keywords


Congenital loss of pain, Visceral pain, SCN11A mutation, Sodium channelopathy

References


  1. Cox, J.J., F. Reimann, A.K. Nicholas, et al. 2006. An SCN9A channelopathy causes congenital inability to experience pain. Nature 444: 894–898.
  2. Goldberg YP, MacFarlane J, MacDonald ML, et al. Loss-of-function mutations in theNav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin. Genet.2007; 71: 311–319.
  3. Fertleman CR, Ferrie CD, Aicardi J, et al. Paroxysmal extreme pain disorder (previously familial rectal pain syndrome). Neurology. 2007;69(6):586-95.
  4. Leipold E, Liebmann L, Korenke GC, et al. A de novo gain-of-function mutation in SCN11A causes loss of pain perception. Nat Genet. 2013 Nov;45(11):1399-404.

Conference registration is required in order to view papers.